Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Litchman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Dermatologic Clinics|June 28, 2025
Lesional Markers and Precursors of MelanomaValerie Foy, Graham H Litchman
Journal of Drugs in Dermatology : JDD|February 4, 2021
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based InteractionsJustin W Marson, Graham H Litchman, Darrell S Rigel
The Journal of Clinical and Aesthetic Dermatology|June 4, 2026
Severe Nail Psoriasis and Early Psoriatic Arthritis: Illustrative Cases Confirming That Severity of Disease Is Not Solely Dependent on the Extent of Body Surface AreaGraham H Litchman, Diego Ruiz Dasilva, James Q Del Rosso
Journal of Drugs in Dermatology : JDD|October 5, 2019
Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by DermatologistsTeplitz Rebeca, Prado Giselle, Graham H. Litchman, et al.
Clinical Nuclear Medicine|July 1, 1986
Computerized blood-flow analysis in osteochondritis dissecansR W McCullough, E J Gandsman, H Litchman, et al.
The Journal of Clinical and Aesthetic Dermatology|July 16, 2026
Resolution of Long-Standing Irritable Bowel Syndrome Symptoms After Treatment of Psoriasis With RisankizumabJose Gaspar de Alba, Marley Cutrona, Ahuva Cices, et al.
Current Medical Research and Opinion|May 7, 2020
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinomaGraham H Litchman, Alison L Fitzgerald, Sarah J Kurley, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19Justin W Marson, Rebecca M Chen, Maham Ahmad, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|March 30, 2022
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working GroupAaron S Farberg, Justin W Marson, Alex Glazer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|June 28, 2025
Lesional Markers and Precursors of MelanomaValerie Foy, Graham H Litchman
Journal of Drugs in Dermatology : JDD|February 4, 2021
The Impact of the COVID-19 Pandemic on Physician-Pharmaceutical Office-Based InteractionsJustin W Marson, Graham H Litchman, Darrell S Rigel
The Journal of Clinical and Aesthetic Dermatology|June 4, 2026
Severe Nail Psoriasis and Early Psoriatic Arthritis: Illustrative Cases Confirming That Severity of Disease Is Not Solely Dependent on the Extent of Body Surface AreaGraham H Litchman, Diego Ruiz Dasilva, James Q Del Rosso
Journal of Drugs in Dermatology : JDD|October 5, 2019
Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by DermatologistsTeplitz Rebeca, Prado Giselle, Graham H. Litchman, et al.
Clinical Nuclear Medicine|July 1, 1986
Computerized blood-flow analysis in osteochondritis dissecansR W McCullough, E J Gandsman, H Litchman, et al.
The Journal of Clinical and Aesthetic Dermatology|July 16, 2026
Resolution of Long-Standing Irritable Bowel Syndrome Symptoms After Treatment of Psoriasis With RisankizumabJose Gaspar de Alba, Marley Cutrona, Ahuva Cices, et al.
Current Medical Research and Opinion|May 7, 2020
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinomaGraham H Litchman, Alison L Fitzgerald, Sarah J Kurley, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19Justin W Marson, Rebecca M Chen, Maham Ahmad, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial ProgramDiego Ruiz Dasilva, Graham H Litchman, Alondra Soto-González, et al.
Dermatology and Therapy|March 30, 2022
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working GroupAaron S Farberg, Justin W Marson, Alex Glazer, et al.
Pageof 2